InvestorsHub Logo
Followers 1
Posts 108
Boards Moderated 0
Alias Born 10/09/2005

Re: None

Thursday, 08/10/2006 7:51:54 PM

Thursday, August 10, 2006 7:51:54 PM

Post# of 346073
Big on Tarvy, While you say the 12 week data on the higher repeat dose trials will not be available .... In my opinion ... I believe the "optimal" repeat dose for HCV will be in the lower half of the dose regimes tested. More is not necessarily better in repeat dose HCV trials.

However it is wise to test the higher doses from a safety standpoint. They could be instrumental in those therapies outside of HCV.

I feel everything is going just fine.

PS Jazz I agree 100% on the safety issue is what's important .. the safety results are looking great.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News